- Home
- CGAU vs OPCH Comparison
CGAU vs OPCH Comparison
Compare CGAU & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CGAU | OPCH |
|---|---|---|
| Founded | 2002 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Nursing Services |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.4B |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CGAU | OPCH |
|---|---|---|
| Price | $18.33 | $20.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | $16.67 | ★ $36.57 |
| AVG Volume (30 Days) | 1.5M | ★ 3.3M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.16% | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | N/A | ★ 0.29 |
| Revenue | N/A | ★ $4,998,202,000.00 |
| Revenue This Year | $25.17 | $7.21 |
| Revenue Next Year | $13.62 | $8.55 |
| P/E Ratio | ★ $11.74 | $71.40 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $6.35 | $18.01 |
| 52 Week High | $21.17 | $36.80 |
Technical Indicators
Market Signals| Indicator | CGAU | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 51.39 | 24.14 |
| Support Level | $17.51 | $18.01 |
| Resistance Level | $20.18 | $29.13 |
| Average True Range (ATR) | 0.78 | 0.95 |
| MACD | -0.07 | -0.61 |
| Stochastic Oscillator | 52.17 | 22.71 |
Price Performance
Historical ComparisonAbout CGAU Centerra Gold Inc.
Centerra Gold Inc is principally focused on operating, developing, exploring and acquiring gold and copper properties in North America, Turkey, and other markets world-wide. The company reportable operating segments are Oksut; Mount Milligan; and Molybdenum. It derives maximum revenue from Mount Milligan segment. Geographically, it operates in Turkey, United States, and Canada.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.